Heme Is a Carbon Monoxide Receptor for Large-Conductance Ca2+-Activated K+ Channels

• Published in: Circulation research 2005-10, Vol.97 (8), p.805-812
• Main Authors: Jaggar, Jonathan H, Li, Anlong, Parfenova, Helena, Liu, Jianxi, Umstot, Edward S, Dopico, Alejandro M, Leffler, Charles W
• Format: Article
• Language: English
• Subjects: Amino Acid Sequence; Animals; Binding Sites; Biological and medical sciences; Carbon Monoxide - metabolism; Carbon Monoxide - pharmacology; Carrier Proteins - metabolism; Cercopithecus aethiops; COS Cells; Fundamental and applied biological sciences. Psychology; Heme - metabolism; Heme - pharmacology; Hemeproteins - metabolism; Hemin - pharmacology; Molecular Sequence Data; Oxygen - pharmacology; Potassium Channels, Calcium-Activated - chemistry; Potassium Channels, Calcium-Activated - drug effects; Potassium Channels, Calcium-Activated - metabolism; Rats; Vertebrates: cardiovascular system
• ISSN: 0009-7330; 1524-4571
• DOI: 10.1161/01.RES.0000186180.47148.7b

Carbon monoxide (CO) is an endogenous paracrine and autocrine gaseous messenger that regulates physiological functions in a wide variety of tissues. CO induces vasodilation by activating arterial smooth muscle large-conductance Ca-activated potassium (BKCa) channels. However, the mechanism by which CO activates BKCa channels remains unclear. Here, we tested the hypothesis that CO activates BKCa channels by binding to channel-bound heme, a BKCa channel inhibitor, and altering the interaction between heme and the conserved heme-binding domain (HBD) of the channel α subunit C terminus. Data obtained using thin-layer chromatography, spectrophotometry, mass spectrometry (MS), and MS-MS indicate that CO modifies the binding of reduced heme to the α subunit HBD. In contrast, CO does not alter the interaction between the HBD and oxidized heme (hemin), to which CO cannot bind. Consistent with these findings, electrophysiological measurements of native and cloned (cbv) cerebral artery smooth muscle BKCa channels show that CO reverses BKCa channel inhibition by heme but not by hemin. Site-directed mutagenesis of the cbv HBD from CKACH to CKASR abolished both heme-induced channel inhibition and CO-induced activation. Furthermore, on binding CO, heme switches from being a channel inhibitor to an activator. These findings indicate that reduced heme is a functional CO receptor for BKCa channels, introduce a unique mechanism by which CO regulates the activity of a target protein, and reveal a novel process by which a gaseous messenger regulates ion channel activity.